openPR Logo

Press Releases from PNS Pharma (125 total)

Global Gene Therapy Market Opportunity By Clinical Trials Pipeline sales Kymriah …

"Global Gene Therapy Market Opportunity & Clinical Trials Insight 2026" Report Highlight: o Global Gene Therapy Market Opportunity: > US$ 8 Billion o Global Gene Therapy Clinical Pipeline: > 1000 Therapies In Clinical Trials o Commercially Available Gene Therapies: 11 o USA Dominates Global Gene Therapy Pipeline: > 500 Therapies In Clinical Trials o Cancer Accounts For 50% of Global Gene Therapy Trials Download Report: https://www.pnspharma.com/buy-report.php?reporttitle=Global-Gene-Therapy-Market-Opportunity-%26-Clinical-Trials-Insight-2026 Over the years, gene therapy has been highly responsible for decreasing the mortality rate

Global Orphan Drug Market Clinical Trials Pipeline Report Market Study 2026

"Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026" Report Highlights: o Global Orphan Drug Market Opportunity: US$ 300 Billion o US Dominates Global Orphan Drug Market: 50% Market Share o US Orphan Drug Opportunity To Surpass: US$ 150 Billion o Global Orphan Drug Clinical Insight: More Than 900 Drugs o Clinical Insight on Marketed Orphan Drugs: More Than 400 Drugs o Oncology To Dominate Orphan Drug Development: 35% Share o FDA & EMA Regulations For Orphan Drugs o Orphan Drug Designation Criteria

Global Rare Disease Drug Market Opportunity To Surpass US$ 300 Billion By 2026

"Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026" Report Highlights: o Global Orphan Drug Market Opportunity: US$ 300 Billion o US Dominates Global Orphan Drug Market: 50% Market Share o US Orphan Drug Opportunity To Surpass: US$ 150 Billion o Global Orphan Drug Clinical Insight: More Than 900 Drugs o Clinical Insight on Marketed Orphan Drugs: More Than 400 Drugs o Oncology To Dominate Orphan Drug Development: 35% Share o FDA & EMA Regulations For Orphan Drugs o Orphan Drug Designation Criteria

Global Orphan Drug Market Opportunity To Surpass US$ 300 Billion By 2026

"Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026" Report Highlights: o Global Orphan Drug Market Opportunity: US$ 300 Billion o US Dominates Global Orphan Drug Market: 50% Market Share o US Orphan Drug Opportunity To Surpass: US$ 150 Billion o Global Orphan Drug Clinical Insight: More Than 900 Drugs o Clinical Insight on Marketed Orphan Drugs: More Than 400 Drugs o Oncology To Dominate Orphan Drug Development: 35% Share o FDA & EMA Regulations For Orphan Drugs o Orphan Drug Designation Criteria

Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026

"Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026" Report Highlights: o Global Orphan Drug Market Opportunity: US$ 300 Billion o US Dominates Global Orphan Drug Market: 50% Market Share o US Orphan Drug Opportunity To Surpass: US$ 150 Billion o Global Orphan Drug Clinical Insight: More Than 900 Drugs o Clinical Insight on Marketed Orphan Drugs: More Than 400 Drugs o Oncology To Dominate Orphan Drug Development: 35% Share o FDA & EMA Regulations For Orphan Drugs o Orphan Drug Designation Criteria

Gene Therapy Clinical Trials Show Promising Future Opportunity With More Than 10 …

Nearly half a century ago, the concept of tinkering the genes and to visualize it in the genotype or phenotype of the patient was not less than a dream but the constant research and efforts by the researchers have made the concept an established protocol in the medical world. The process of gene therapy has made it possible to precisely manipulate the genetic material of an individual and bring the

Peptide Market Size Sales Forecast Clinical Trials Pipeline Insight 2026

"Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026" report highlights: o Global Peptide Therapeutics Market Opportunity: US$ 65 Billion o Peptide Therapeutics Market Opportunity: US$ 22 Billion o Insight Peptide Drugs in Clinical Trials: 807 Peptides Drugs o Clinical & Patent Insight on 197 Marketed Peptides o Peptide Clinical Pipeline Is Dominated by Cyclic Peptides: 46 Peptides o Peptides Clinical Trials Insight by Phase, Indication & Company o Future Peptide Therapeutics Market Outlook Download Report: http://www.pnspharma.com/buy-report.php?reporttitle=Global-Peptide-Therapeutics-Market--%26-Clinical-Pipeline-Insight-2026 "Global Peptide Therapeutics Market

Gene Therapy Market witnessing 35% Growth To Reach USD 8 Billion By 2026

The approach of modifying the genes directly to correct the disease linked with it is one of the most widely accepted and researched field in the pharmaceutical industry. Gene therapy holds significant potential to support various applications in the cancer research sector and other genetic linked diseases. The promising and potential approach of the therapy to treat numerous genetic diseases is making it a successful research sector. Another important potential

Global Gene Therapy Market To Witness Positive Outlook With More Than USD 8 Bill …

Gene therapy process has successfully gained popularity among the researchers all around the globe. Since its discovery, the primary driver of the market of the gene therapy process is considered to be its ability to alter the cause of the disease at the molecular level and that too precisely than the other available technologies. The technological advancements and the development in the gene delivery systems have developed a bright scope

Global Gene Therapy Market Size Sales To Surpass USD 8 Billion By 2026

" Global Gene Therapy Market Opportunity & Clinical Trials Insight 2026" Report Highlights: o Global Gene Therapy market Opportunity: > USD 8 Billion o Global Gene Therapy Pipeline:: > 1000 In Trials o Commercially Available Gene Therapies: 11 o US & Europe Are Key Markets Download Report: http://pnspharma.com/buy-report.php?reporttitle=Global-Gene-Therapy-Market-Opportunity-%26-Clinical-Trials-Insight-2026 1. Introduction to Gene Therapy 1.1 Gene Therapy: An Overview 1.2 History of Development 2. Gene Therapy & its Impact on Genetic Alterations 2.1 Gene Therapy as a Mastermind of Genetic Revolution

Global Breast Cancer Drug Market & Clinical Trial Insight 2025

" Global Breast Cancer Drug Market & Clinical Trial Insight 2025" Report Highlights: • Global Breast Cancer Drug Market: US$ 40 Billion Opportunity • Global Breast Cancer Drug Clinical Pipeline: More Than 550 Drugs • Marketed Breast Cancer Drugs: More Than 90 Drugs • Comprehensive Clinical Insight & Patent Information • Drug Trials, Pricing, Dosage, Cancer Prevalence Insight: 130 Graphs/Charts Download Report: http://pnspharma.com/buy-report.php?reporttitle=Global-Breast-Cancer-Drug-Market-%26-Clinical-Trial-Insight-2025 The applied science research has marked tremendous advancements in cutting off the epidemic cancer scenarios all around the

Global Peptide Drug Therapeutics Market Size Will Reach US$ 65 Billion by 2026

“Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026” report highlights: • Global Peptide Therapeutics Market Opportunity: US$ 65 Billion • Peptide Therapeutics Market Opportunity: US$ 22 Billion • Insight Peptide Drugs in Clinical Trials: 807 Peptides Drugs • Clinical & Patent Insight on 197 Marketed Peptides • Peptide Clinical Pipeline Is Dominated by Cyclic Peptides: 46 Peptides • Peptides Clinical Trials Insight by Phase, Indication & Company • Future Peptide Therapeutics Market Outlook Download Report: http://pnspharma.com/buy-report.php?reporttitle=Global-Peptide-Therapeutics-Market--%26-Clinical-Pipeline-Insight-2026 “Global Peptide Therapeutics Market

Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026

The global peptide drug market is expected to surpass US$ 50 Billion by 2026 as per recent report "Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026" published by PNS Pharma. Report gives comprehensive insight on ongoing clinical trials of more than 800 peptide drugs across the globe. Report has more than 140 graphs and charts to represent peptide clinical trials data, available drug dosage, price insight and patent

Global Cancer Vaccine Market & Clinical Trial Insight 2025

Recent published report “Global Cancer Vaccine Market & Clinical Trial Insight 2025“ by PNS Pharma highlights on going developments in the field of cancer vaccine market research and clinical trials. currently there are more than 15 cancer vaccines commercially available in the market and close to 370 are in clinical Trial or pipeline. Most of the vaccines in development phases are for the treatment of Breast cancer and

Global Orphan Drug Pipeline & Regulatory Insight 2025

” Global Orphan Drug Pipeline & Regulatory Insight 2025” Report Highlights: Global Orphan Drug Market Overview: US$ 260 Billion Opportunity Global Orphan Drug market by Segment Regulatory Landscape: USA, Europe & Asia Orphan Drug Designation & Reimbursement Policy: USA, Europe & Asia Global Orphan Drug Clinical Pipeline Insight: 973 Drugs Marketed Orphan Drug Clinical Insight: 366 Drugs Download Report: http://www.pnspharma.com/buy-report.php?reporttitle=Global-Orphan-Drug-Pipeline-%26-Regulatory-Insight-2025 Report TOC Orphan Drugs: Regimens For Rare Diseases Drivers of Orphan Drug Commercialization 2.1 Cost

Global Orphan Drug Pipeline & Regulatory Insight 2025

” Global Orphan Drug Pipeline & Regulatory Insight 2025″ Report Highlights: Global Orphan Drug Market Overview: US$ 260 Billion Opportunity Global Orphan Drug market by Segment Regulatory Landscape: USA, Europe & Asia Orphan Drug Designation & Reimbursement Policy: USA, Europe & Asia Global Orphan Drug Clinical Pipeline Insight: 973 Drugs Marketed Orphan Drug Clinical Insight: 366 Drugs Download Report: http://www.pnspharma.com/buy-report.php?reporttitle=Global-Orphan-Drug-Pipeline-%26-Regulatory-Insight-2025 Orphan Drugs: Regimens For Rare Diseases Drivers of Orphan Drug Commercialization 2.1 Cost

Global Cancer Vaccine Market & Clinical Trial Insight 2025

Global Cancer Vaccine Market & Clinical Trial Insight 2025″ Report Highlight: Global Cancer Vaccine Market Opportunity: US$ 15 Billion Opportunity Personalized Cancer Vaccine: The Next growth Frontier Global Cancer Vaccine Clinical insight by Indication & Phase of Development Global Cancer Vaccine Pipeline: 369 Cancer Vaccines Marketed Cancer Vaccines: 17 Cancer Vaccines Maximum Vaccines in Pipeline for Brain & Breast Cancer: 43 Cancer Vaccines Regulatory Landscape Download Report: http://www.pnspharma.com/buy-report.php?reporttitle=Global-Cancer-Vaccine-Market-%26-Clinical-Trial-Insight-2025 Introduction to Cancer Vaccines Mechanism

Global Orphan Drug Market Offers USD 250 Billion Opportunity By 2025

Download Report: http://www.pnspharma.com/buy-report.php?reporttitle=Global-Orphan-Drug-Pipeline-%26-Regulatory-Insight-2025 Total sales of orphan designated drugs is expected to surpass US$ 250 Billion by 2025 as per recent report “Global Orphan Drug Pipeline & Regulatory Insight 2025” published by PNS Pharma. The strong clinical pipeline and availability of more than 350 orphan designated drugs in the market will drive the global orphan drug market in coming years. "Global Orphan Drug Pipeline & Regulatory Insight 2025" Report Highlights: • Global Orphan Drug

Global Cancer Vaccine Market Opportunity Valued At USD 15 Billion

Download Report: http://www.pnspharma.com/buy-report.php?reporttitle=Global-Cancer-Vaccine-Market-%26-Clinical-Trial-Insight-2025 "Global Cancer Vaccine Market & Clinical Trial Insight 2025” Report Highlight: • Global Cancer Vaccine market Opportunity: US$ 15 Billion opportunity • Personalized Cancer Vaccine: The Next growth Frontier • Global Cancer Vaccine Clinical insight by Indication & Phase of Development • Global Cancer Vaccine Pipeline: 369 Cancer Vaccines • Marketed Cancer Vaccines: 17 Cancer Vaccines • Maximum Vaccines in Pipeline for Brain & Breast Cancer: 43 Cancer Vaccines • Regulatory Landscape The cancer vaccine market is expected to reach USD 15 Billion

Orphan Drug Pipeline & Regulatory Insight 2025

Orphan Drug Pipeline & Regulatory Insight 2025" Report Highlights: Global Orphan Drug Market Overview: US$ 260 Billion Opportunity Global Orphan Drug market by Segment Regulatory Landscape: USA, Europe & Asia Orphan Drug Designation & Reimbursement Policy: USA, Europe & Asia Global Orphan Drug Clinical Pipeline Insight: 973 Drugs Marketed Orphan Drug Clinical Insight: 366 Drugs The global orphan drug market opportunity is expected to surpass US$ 260 Billion by 2025 as per

Global Cancer Monoclonal Antibodies Market &Clinical Trial Insight 2024

" Global Cancer Monoclonal Antibodies Market &Clinical Trial Insight 2024" Report Highlights: * Significance for Monoclonal Antibodies for Cancer Treatment * Global Cancer Monoclonal Antibodies Market Overview * Global Cancer Monoclonal Antibodies Pipeline by Phase & Indication * Global Cancer Monoclonal Antibodies Pipeline: 697 mAb * Marketed Cancer Monoclonal Antibodies: 60 * Global Cancer Monoclonal Antibodies Market Opportunity: US$ 140 Billion The recent years have witnessed the emergence of monoclonal antibodies, which has the potential

Global Orphan Drug Pipeline & Regulatory Insight 2025

" Global Orphan Drug Pipeline & Regulatory Insight 2025" Report Highlights: * Global Orphan Drug Market Overview: US$ 260 Billion Opportunity * Global Orphan Drug market by Segment * Regulatory Landscape: USA, Europe & Asia * Orphan Drug Designation & Reimbursement Policy: USA, Europe & Asia * Global Orphan Drug Clinical Pipeline Insight: 973 Drugs * Marketed Orphan Drug Clinical Insight: 366 Drugs Download Report: http://www.pnspharma.com/buy-report.php?reporttitle=Global-Orphan-Drug-Pipeline-%26-Regulatory-Insight-2025 Contact For Report Sample: rajesj@pnspharma.com The global orphan drug market

Global Peptide Drug Market To Surpass USD 50 Billion by 2024

Global peptide drug market is expected to surpass US$ 50 billion by 2024 as per recent report published by PNS Pharma. Currently there are more than 600 peptide drug in clinical pipeline and more than 100 are commercially available in the market. “Global Peptide Therapeutics Market, Dosage, Price & Clinical Trials Insight 2024” Report Highlight: * Global Peptide Therapeutics Market Opportunity: More Than US$ 50 Billion * Cost Analysis & Market Insight into

Global Peptide Therapeutics Market, Dosage, Price & Clinical Trials Insight 2024 …

“Global Peptide Therapeutics Market, Dosage, Price & Clinical Trials Insight 2024” Report Highlight: * Global Peptide Therapeutics Market Opportunity: More Than US$ 50 Billion * Cost Analysis & Market Insight into its Application * Dosage & Sales Analysis of Key Drugs * Global Peptide Drug Clinical Pipeline: 612 Drugs * Peptide Drug Application by Indication * Global Peptide Pipeline by Indication, Company & Phase * Marketed Peptide Drugs: 101 Drugs * Clinical Trials Insight by Peptide Classification Download

Peptide Therapeutics Market, Dosage, Price & Clinical Trials Insight 2024

“Global Peptide Therapeutics Market, Dosage, Price & Clinical Trials Insight 2024” Report Highlight: * Global Peptide Therapeutics Market Opportunity: More Than US$ 50 Billion * Cost Analysis & Market Insight into its Application * Dosage & Sales Analysis of Key Drugs * Global Peptide Drug Clinical Pipeline: 612 Drugs * Peptide Drug Application by Indication * Global Peptide Pipeline by Indication, Company & Phase * Marketed Peptide Drugs: 101 Drugs * Clinical Trials Insight by Peptide

Global Peptide Therapeutics Market, Dosage, Price & Clinical Trials Insight 2024

“Global Peptide Therapeutics Market, Dosage, Price & Clinical Trials Insight 2024” Report Highlight: * Global Peptide Therapeutics Market Opportunity: More Than US$ 50 Billion * Cost Analysis & Market Insight into its Application * Dosage & Sales Analysis of Key Drugs * Global Peptide Drug Clinical Pipeline: 612 Drugs * Peptide Drug Application by Indication * Global Peptide Pipeline by Indication, Company & Phase * Marketed Peptide Drugs: 101 Drugs * Clinical Trials Insight by Peptide

Global Cancer Peptide Drug Market To Surpass USD 16 Billion By 2024

“Global Peptide Therapeutics Market & Clinical Trials Insight 2022” report highlight * Fundamentals of Peptide Therapeutics * Peptide Therapeutics by Applications & Indications * Peptides Clinical Trials Insight by Phase, Indication & Company * Insight on 688 Peptide Drugs in Clinical Trials * Clinical & Patent Insight on 119 Marketed Peptides * Future Peptide Therapeutics Market Outlook Download Report Sample Weblink: http://pnspharma.com/buy-report.php?reporttitle=Global-Peptide-Therapeutics-Market-%26-Clinical-Trials-Insight-2022 For Report Sample Contact: rajesh@pnspharma.com Table of Contents 1. A Revolution of Peptide Therapeutics

Global Cancer Peptide Drug Market To Surpass USD 16 Billion By 2024

“Global Peptide Therapeutics Market & Clinical Trials Insight 2022” report highlight * Fundamentals of Peptide Therapeutics * Peptide Therapeutics by Applications & Indications * Peptides Clinical Trials Insight by Phase, Indication & Company * Insight on 688 Peptide Drugs in Clinical Trials * Clinical & Patent Insight on 119 Marketed Peptides * Future Peptide Therapeutics Market Outlook Download Report Sample Weblink: http://pnspharma.com/buy-report.php?reporttitle=Global-Peptide-Therapeutics-Market-%26-Clinical-Trials-Insight-2022 For Report Sample Contact: rajesh@pnspharma.com Table of Contents 1. A Revolution of Peptide Therapeutics

Global Peptide Drug Market To Surpass USD 45 Billion By 2024

“Global Peptide Therapeutics Market & Clinical Trials Insight 2022” report highlight * Fundamentals of Peptide Therapeutics * Peptide Therapeutics by Applications & Indications * Peptides Clinical Trials Insight by Phase, Indication & Company * Insight on 688 Peptide Drugs in Clinical Trials * Clinical & Patent Insight on 119 Marketed Peptides * Future Peptide Therapeutics Market Outlook Download Report Sample Weblink: http://pnspharma.com/buy-report.php?reporttitle=Global-Peptide-Therapeutics-Market-%26-Clinical-Trials-Insight-2022 For Report Sample Contact: rajesh@pnspharma.com Table of Contents 1. A Revolution of Peptide Therapeutics

Global Peptide Therapeutics Market & Clinical Trials Insight 2022

“Global Peptide Therapeutics Market & Clinical Trials Insight 2022” report highlight * Peptide Therapeutics by Applications & Indications * Peptides Clinical Trials Insight by Phase, Indication & Company * Insight on 688 Peptide Drugs in Clinical Trials * Clinical & Patent Insight on 119 Marketed Peptides * Future Peptide Therapeutics Market Outlook Download Report Sample Weblink: http://pnspharma.com/buy-report.php?reporttitle=Global-Peptide-Therapeutics-Market-%26-Clinical-Trials-Insight-2022 For Report Sample Contact: neeraj@kuickresearch.com Table of Contents 1. A Revolution of Peptide Therapeutics 1.1 Peptides as Drug

Global Peptide Drug Market To Surpass USD 35 Billion by 2022

“Global Peptide Therapeutics Market & Clinical Trials Insight 2022” report highlight * Fundamentals of Peptide Therapeutics * Peptide Therapeutics by Applications & Indications * Peptides Clinical Trials Insight by Phase, Indication & Company * Insight on 688 Peptide Drugs in Clinical Trials * Clinical & Patent Insight on 119 Marketed Peptides * Future Peptide Therapeutics Market Outlook “Global Peptide Therapeutics Market & Clinical Trials Insight 2022” report gives comprehensive insight into the various clinical and non-clinical issues

Europe Breast Cancer Drug Pipeline Analysis

The pharmaceutical companies have recently been focusing increasingly on women's health. Among the diseases specific to women, breast cancer has become one of the leading causes of death for the women population globally and accounts for almost 3 per cent of the causes of death in women. It has been estimated that one in every 12 women is most likely to develop breast cancer at some point in her life,

US Breast Cancer Drug Pipeline Analysis

The pharmaceutical companies have recently been focusing increasingly on women's health. Among the diseases specific to women, breast cancer has become one of the leading causes of death for the women population globally and accounts for almost 3 per cent of the causes of death in women. It has been estimated that one in every 12 women is most likely to develop breast cancer at some point in her life,

US Prostate Cancer Drug Pipeline Analysis

Prostate cancer has emerged as one of the most commonly diagnosed cancer among men in the US. According to the American Cancer Society, there were close to 242,000 new cases of prostate cancer in the US in 2012, with 28,000 men dying from it. This was an increase from 206,640 men diagnosed with the condition during 2009. The number of men being actively treated for prostrate disorders such as benign

US Alzheimer Drug Pipeline Analysis

In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,

Orphan Drugs for Cancer Pipeline Analysis

A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being developed

Global HIV Infection Pipeline Analysis

The discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retrovirals in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have

Global Infertility Drug Pipeline Analysis

The market for reproductive medicine is experiencing a paradigm shift with new latest techniques being used and awareness among people increasing due to imparting knowledge about these techniques. The infertility drugs market promises significant room for growth. The market has high potential to scale up in order to meet the needs of infertile couples and also due to growth in reproductive tourism. Venture capitalists have entered the market by investing

US Orphan Drug Pipeline Analysis

In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry.

Global Oncolytic Virus Therapy Pipeline Analysis

Though still in nascent stages, Oncolytic viruses have shown immense opportunities and potential to be tapped in the future to improve the treatment of cancer and the lives of the patients. Immunotherapy, the umbrella for Oncolytic viruses would not offer cures, but survival solutions with significant importance. Also, the side effects of this therapy would be tolerable by the patients, which could thus become the most important approach to treat

Global DNA Vaccine Pipeline Analysis

he global market for DNA vaccines is currently recording significant growth rates owing to the lesser side effects, ease of development, lesser cost and continued development in biotechnology arena. At present, not even a single DNA vaccine has been approved for human beings. However, around 100 products are under clinical trial for treating diseases like HIV infection, cancer and other infectious diseases. With regards to animal health, there are three

Global RNAi Drug Pipeline Analysis

“Global RNAi Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed based upon RNAi technology. Research report covers all the ongoing drugs being developed in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each drug profile in

Global Cancer Vaccines Pipeline Analysis

Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. With the approval of the expensive prostate cancer vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented boost. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into which the cancer vaccines market is categorized. North America has the largest share

Global Cell Therapy Pipeline Analysis

“Global Cell Therapy Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Cell Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight

Gene Therapy Drug Pipeline Analysis

“Gene Therapy Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight

Pancreatic Cancer Drug Pipeline Analysis

“Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Pancreatic Cancer. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each

Hepatitis C Drug Pipeline Analysis

“Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Hepatitis C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each

Malaria Disease Drug Pipeline Analysis

“Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Malaria. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug

Europe Orphan Drugs Pipeline Analysis

“Europe Orphan Drugs Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles under Orphan Drugs status in Europe. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. The information for particular drug

US Parkinson’s Disease Drug Pipeline Analysis

Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds

Go To Page:   1 2 3 4 5 6 7 8 9 10